As a result, EA was effective in downregulating CRF-R1 expression in the hypothalamus and IMMC, decreasing the expression of hypothalamus CRF, alleviating rats' visceral hypersensitivity and anxiety and depression-like behaviours, and meeting with Wu HG's research [37]. Here, CRHR1 is linked to major depressive disorder.